180 related articles for article (PubMed ID: 28387097)
1. [New paradigms and metaphors in cutaneous melanoma treatment].
Piérard GE; Nizet JL; Humbert P
Rev Med Liege; 2016 Dec; 71(12):562-566. PubMed ID: 28387097
[TBL] [Abstract][Full Text] [Related]
2. [Metastatic melanoma: some hope from ipilimumab and vemurafenib].
Piérard-Franchimont C; Piérard GE
Rev Med Liege; 2012 Feb; 67(2):64-8. PubMed ID: 22482234
[TBL] [Abstract][Full Text] [Related]
3. Advances in the treatment of melanoma.
Lacy KE; Karagiannis SN; Nestle FO
Clin Med (Lond); 2012 Apr; 12(2):168-71. PubMed ID: 22586796
[No Abstract] [Full Text] [Related]
4. Narrowing the knowledge gaps for melanoma.
Slipicevic A; Herlyn M
Ups J Med Sci; 2012 May; 117(2):237-43. PubMed ID: 22339359
[TBL] [Abstract][Full Text] [Related]
5. Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapy.
Nomura H; Takahashi H; Suzuki S; Kurihara Y; Chubachi S; Kawada I; Yasuda H; Betsuyaku T; Amagai M; Funakoshi T
J Dermatol; 2017 Jul; 44(7):818-821. PubMed ID: 28295542
[TBL] [Abstract][Full Text] [Related]
6. Novel therapies in melanoma.
Scheier B; Amaria R; Lewis K; Gonzalez R
Immunotherapy; 2011 Dec; 3(12):1461-9. PubMed ID: 22091682
[TBL] [Abstract][Full Text] [Related]
7. New targeted therapies in melanoma.
Kudchadkar RR; Gonzalez R; Lewis K
Cancer Control; 2013 Oct; 20(4):282-8. PubMed ID: 24077404
[TBL] [Abstract][Full Text] [Related]
8. The rapidly evolving therapies for advanced melanoma--Towards immunotherapy, molecular targeted therapy, and beyond.
Zhu Z; Liu W; Gotlieb V
Crit Rev Oncol Hematol; 2016 Mar; 99():91-9. PubMed ID: 26708040
[TBL] [Abstract][Full Text] [Related]
9. What new immunotherapeutic techniques are currently being investigated for the treatment of melanoma?
Donnelly OG; Melcher AA; Vile RG; Pulido J
Immunotherapy; 2012 Aug; 4(8):749-51. PubMed ID: 22947000
[No Abstract] [Full Text] [Related]
10. The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma.
Dummer R; Siano M; Hunger RE; Lindenblatt N; Braun R; Michielin O; Mihic-Probst D; von Moos R; Najafi Y; Guckenberger M; Arnold A
Swiss Med Wkly; 2016; 146():w14279. PubMed ID: 26901103
[TBL] [Abstract][Full Text] [Related]
11. Current advances and perspectives in the treatment of advanced melanoma.
Livingstone E; Zimmer L; Vaubel J; Schadendorf D
J Dtsch Dermatol Ges; 2012 May; 10(5):319-25. PubMed ID: 22432863
[TBL] [Abstract][Full Text] [Related]
12. Ipilimumab and vemurafenib: two different routes for targeting melanoma.
Burgeiro A; Mollinedo F; Oliveira PJ
Curr Cancer Drug Targets; 2013 Oct; 13(8):879-94. PubMed ID: 23862981
[TBL] [Abstract][Full Text] [Related]
13. Systemic therapy for metastatic melanoma in 2012: dawn of a new era.
Bhatia S; Thompson JA
J Natl Compr Canc Netw; 2012 Mar; 10(3):403-12. PubMed ID: 22393198
[TBL] [Abstract][Full Text] [Related]
14. [Malignant melanoma].
Schmid-Wendtner M; Wendtner CM
Dtsch Med Wochenschr; 2012 Dec; 137(49):2548-50. PubMed ID: 23188634
[No Abstract] [Full Text] [Related]
15. Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo.
Fukumoto T; Fujiwara S; Sakaguchi M; Oka M; Kiyota N; Ejima Y; Nakajima K; Nishigori C
Eur J Dermatol; 2017 Apr; 27(2):177-178. PubMed ID: 27873735
[No Abstract] [Full Text] [Related]
16. [Advances in immunotherapy for metastatic melanoma].
Oláh J
Magy Onkol; 2017 Jun; 61(2):132-136. PubMed ID: 28585614
[TBL] [Abstract][Full Text] [Related]
17. Advances in the management of melanoma: targeted therapy, immunotherapy and future directions.
Dean E; Lorigan P
Expert Rev Anticancer Ther; 2012 Nov; 12(11):1437-48. PubMed ID: 23249108
[TBL] [Abstract][Full Text] [Related]
18. [Management of patients with metastatic cutaneous melanoma: French national guidelines. French National Cancer Institute].
Leccia MT; Planchamp F; Sassolas B; Combemale P; Modiano P; Bedane C; Cupissol D; Derrey S; Dygai-Cochet I; Lamant L; Lubrano V; Mirabel X; Mourrégot A; Rougé Bugat ME; Siegrist S; Thariat J; Tiffet O; Truc G; Verdoni L; Mazeau-Woynar V
Ann Dermatol Venereol; 2014 Feb; 141(2):111-21. PubMed ID: 24507205
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic strategies and systemic treatment of brain melanoma metastases].
Durando X; Mansard S; Daste A; Gimbergues P; Brocard L; Magné N; Thivat E
Bull Cancer; 2013 Jan; 100(1):23-8. PubMed ID: 22889847
[TBL] [Abstract][Full Text] [Related]
20. Current systemic therapies for melanoma.
Palathinkal DM; Sharma TR; Koon HB; Bordeaux JS
Dermatol Surg; 2014 Sep; 40(9):948-63. PubMed ID: 25072125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
